Arvinas, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
Arvinas stock last closed at $9.62, up 2.67% from the previous day, and has decreased 69.72% in one year. It has overperformed other stocks in the Biotechnology industry by 0.07 percentage points. Arvinas stock is currently +62.09% from its 52-week low of $5.94, and -74.26% from its 52-week high of $37.38.
At the moment, there are 68.77M ARVN shares outstanding. The market capitalization of ARVN is $661.59M. In the past 24 hours, 1.52M ARVN shares were traded.
How to Buy Arvinas Stock
Not sure how to invest in Arvinas stock? Here's how.
Figure out where to buy Arvinas stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you figure out where to buy Arvinas stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your brokerage account: Select your method of payment and add your details.
Research Arvinas stock: The Arvinas ticker symbol is ARVN. Is Arvinas stock a good investment? Should you buy shares of ARVN? How do ARVN's underlying business fundamentals look? Do top analysts think Arvinas is a good buy? Why has ARVN's stock price moved recently? (Hint: Our stock research tools can help you figure out if ARVN is a good stock to buy).
Execute your ARVN buy order: Decide if you will purchase ARVN shares at the current market price or use a limit order to buy ARVN shares at a given price.
Monitor your investment in ARVN: Create a watchlist to the latest updates on your investment in Arvinas shares.
Step 1: Figure out where to buy Arvinas stock
You need a brokerage account in order to access the NASDAQ market and buy ARVN stock.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal information so you can invest in ARVN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Arvinas stock
Once you have chosen the best place to buy Arvinas stock, it's important to research their stock prior to buying, so you actually comprehend the risk and opportunity.
Arvinas shares data
ARVN Price
$9.62
1w %
6.06%
1y %
-69.72%
5y %
-81.68%
P/E
-3.47x
P/B
1.18x
P/S
2.63x
PEG
N/A
Revenue
$263.40M
Earnings
-$198.90M
Fore. Rev. Growth
-12.22%
Fore. Earn. Growth
N/A
Market Cap
$661.59M
Next Earnings
May 1, 2025
Next Dividend
N/A
Arvinas Due Diligence Score
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
There are more short-term assets than short-term liabilities on the ARVN balance sheet.
There are more short-term assets than long-term liabilities on the ARVN balance sheet.
ARVN has cash burn of 261000000. It has enough cash and short-term investments to cover this for at least one year.
ARVN has $1.04B in cash and short term investments. This is sufficient to cover its annual cash burn of $261.00M.
Failed Financial Due Diligence Checks:
Total ARVN debt is higher than 5 years ago, relative to shareholder equity.
ARVN has a relatively high debt to equity ratio of 0.94.
ARVN profit margin has gone up by 3.92 percentage points in the past year, but the company is still unprofitable.
Is ARVN stock a Buy, Hold, or Sell, according to analysts?
Out of 14 Equities analysts who give forecasts on ARVN, the consensus analyst rating on ARVN is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent ARVN Analyst Ratings
Derek Archila, a top 2% analyst from Wells Fargo maintains ARVN with a strong buy rating and lowers their ARVN price target from $60.00 to $26.00, on Mar 12, 2025.
Etzer Darout, a top 14% analyst from BMO Capital maintains ARVN with a buy rating and lowers their ARVN price target from $82.00 to $20.00, on Mar 12, 2025.
Robert Driscoll, a top 24% analyst from Wedbush downgrades ARVN to a hold rating and lowers their ARVN price target from $57.00 to $12.00, on Mar 12, 2025.
Tazeen Ahmad, a bottom 8% analyst from Bank of America maintains ARVN with a strong buy rating and lowers their ARVN price target from $54.00 to $28.00, on Mar 12, 2025.
Yigal Nochomovitz, a top 13% analyst from Citigroup maintains ARVN with a hold rating and lowers their ARVN price target from $28.00 to $19.00, on Mar 7, 2025.
You can dive deeper into what analysts are projecting on the Arvinas stock forecast page.
ARVN Momentum
SMA10
8.94
SMA20
7.89
SMA50
10.71
SMA100
14.99
SMA200
20.48
MACD
-0.13
MACD Signal
-0.59
MACD Histogram
0.46
RSI
58.05
Stochastic %K
95.84
Stochastic %D
95.07
StochRSI %K
100
StochRSI %D
99.29
ARVN Revenue
Last year, ARVN revenue was $263.40M. In the last 5 year, ARVN's revenue has grown by 43.69% per year. This was slower than the Biotechnology industry average of 45.66%.
No, Arvinas doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your ARVN buy order
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly fine.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Hit the Open button and your broker will execute your order.
If you need more help investing in stocks on eToro, watch the helpful video below:
As of Apr 30, 2025, it costs $9.62 to buy one share of Arvinas stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.416 shares of ARVN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.